Manufacturer Meloxicam Powder Synthetic EP Grade For Rheumatoid arthritis
Meloxicam Specification
Product Name: Meloxicam
CAS: 71125-38-7
Standard: EP
Natural/Synthetic: Synthetic
Level: Pharmaceutical grade
Content: 99%
Appearance: light yellow powder
Packing: 25kg/cardboard drum
Ingredients: Meloxicam
Category: Pharmaceutical Raw Materials
Industry: Pharmaceuticals
Field: Pharmaceutical Raw Materials
Deferred products: meloxicam tablets, meloxicam dispersible tablets, preparations
Application: Symptomatic treatment for rheumatoid arthritis, symptomatic treatment of painful osteoarthritis (arthropathy, degenerative osteoarthrosis)
Usage and dosage: Oral. The daily dose should not exceed 15 mg/day. Patients with severe renal failure requiring dialysis should not exceed 7.5 mg/day. 1. When symptoms of osteoarthritis worsen: 1 tablet at a time, once daily, if the symptoms do not improve, the dose may be increased to 2 tablets once a day, once a day; each tablet is 7.5 mg. 2. Rheumatoid arthritis and ankylosing spondylitis: 2 tablets at a time, once daily, according to the response after treatment, the dose can be reduced to one tablet at a time, once a day; 7.5 mg per tablet.
What is Meloxicam?
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and fever reducer effects. It is an oxicam closely related to piroxicam, and falls in the enolic acid group of NSAIDs.
Meloxicam Certificate of Analysis
| Product name |
Meloxicam |
| CAS No. |
71125-38-7 |
Outer Packing |
20kg/drum |
| Production date |
2017-12-29 |
Shelf life |
2020-12-28 |
| Standard adopted |
EP8.0 |
| Items of analysis |
Specification |
Results |
| Appearance |
A pale yellow powder |
A pale yellow powder |
| Identification |
Should comply with the IR spectrum
|
Comply with the IR spectrum |
| Related substances |
|
|
| Impurity A |
≤0.1％ |
＜0.03％ |
| Impurity B |
≤0.1％ |
Not detected |
| Impurity C |
≤0.05％ |
Not detected |
| Impurity D |
≤0.05％ |
＜0.03％ |
| Any other impurity |
≤0.10％ |
＜0.03％﹙350nm﹚ |
| Total impurities |
≤0.3％ |
0.07％ |
| Heavy Metals |
≤20ppm |
＜20 ppm |
| Loss on drying |
≤0.5％ |
0.03％ |
| Sulphated ash |
≤0.1％ |
0.02％ |
| Assay,on dried basis |
99.0％~101.0％ |
99.5％ |
| Residual solvents |
|
|
| Ethanol |
≤5000ppm |
263ppm |
| Xylene |
≤2170 ppm |
Not detected |
| Conclusion |
Qualified |
Meloxicam Application
Meloxicam is used to treat arthritis. It reduces pain, swelling, and stiffness of the joints.
